It was found, that in models of IBD, secreted IL-18 potentiates IL-18 responsiveness via augmentation of lamina propria CD4+ T cell IL-18 receptor expression and that IL-18 signalling restricts intestinal inflammation by limiting the Th17 differentiation and promoting Treg effector responses [69]. This evidence concerns the gene CD4 and inflammatory bowel disease.